235.00NOK-0.42%Mkt Cap: 4.22B NOKP/E: 27.08Last update: 2026-05-13
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)27.08
P/E (Forward)24.33
PEG2.35
P/B9.02
P/S5.87
EV/EBITDA20.20
EV/Revenue5.62
EPS (TTM)8.55
EPS (Forward)9.49
Cash Flow & Leverage
FCF Yield2.77%
FCF Margin16.23%
Operating CF191.57M NOK
CapEx (TTM)—
Net Debt/EBITDA-0.87
Net Debt-175.19M NOK
Technical
SMA 50221.10 (+6.3%)
SMA 200236.41 (-0.6%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)26.11K
Avg Vol (10d)35.81K
Technical Indicators
RSI (14)59.1
MACD2.4043
MACD Signal2.4785
MACD Hist.-0.0742
BB Upper238.41 NOK
BB Middle230.30 NOK
BB Lower222.19 NOK
BB Width7.04%
ATR (14)8.865 NOK
Vol Ratio (20d)0.82x
52W Range
185.0047% of range292.00
52W High292.00 NOK
52W Low185.00 NOK
Profitability
Gross Margin81.68%
EBITDA Margin27.83%
Profit Margin22.75%
Oper. Margin28.31%
ROE33.99%
ROA24.10%
Revenue Growth11.10%
Earnings Growth—
Balance Sheet
Debt/Equity0.08
Current Ratio3.80
Quick Ratio2.56
Book Value/Sh25.62 NOK
Cash/Share11.47 NOK
Dividends
Fwd Div Rate8.000 NOK
Trail. Div Rate8.000 NOK
Div. Yield3.46%
5Y Avg Yield1.99%
Payout Ratio70.26%
Ex-Div DateMay 7, 2026
Pay Date—
Ownership
Shares Out.18.28M
Float11.31M
Insiders7.49%
Institutions58.45%
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)315.00 NOK
Target Range310.00 NOK – 320.00 NOK
# Analysts2
Company
Market Cap4.22B NOK
Enterprise Value4.05B NOK
Revenue (TTM)719.89M NOK
Gross Profit571.59M NOK
Net Income (TTM)159.21M NOK
Revenue/Share38.29 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees159
Last Price235.00 NOK
CountryNO
SectorHealthcare
IndustryMedical Devices
ISINNO0010159684